Entity Common Stock, Shares Outstanding of CRISPR Therapeutics AG from 21 Nov 2016 to 10 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CRISPR Therapeutics AG quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 21 Nov 2016 to 10 Feb 2026.
  • CRISPR Therapeutics AG Entity Common Stock, Shares Outstanding for the quarter ending 10 Feb 2026 was 95,985,312, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CRISPR Therapeutics AG Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 95,985,312 +10,210,838 +12% 10 Feb 2026 10-K 12 Feb 2026 2025 FY
Q3 2025 95,300,233 +9,946,754 +12% 06 Nov 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 90,950,423 +5,782,265 +6.8% 01 Aug 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 86,363,684 +1,445,591 +1.7% 02 May 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 85,774,474 07 Feb 2025 10-K 11 Feb 2025 2024 FY
Q3 2024 85,353,479 +5,921,033 +7.5% 01 Nov 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 85,168,158 +5,756,708 +7.2% 01 Aug 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 84,918,093 +5,982,995 +7.6% 03 May 2024 10-Q 08 May 2024 2024 Q1
Q3 2023 79,432,446 +1,138,307 +1.5% 02 Nov 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 79,411,450 +1,402,190 +1.8% 03 Aug 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 78,935,098 +1,478,017 +1.9% 05 May 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 78,294,139 +1,767,175 +2.3% 28 Oct 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 78,009,260 +1,808,075 +2.4% 04 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 77,457,081 +1,688,145 +2.2% 05 May 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 77,067,587 +1,638,660 +2.2% 11 Feb 2022 10-K 15 Feb 2022 2021 FY
Q3 2021 76,526,964 +5,874,535 +8.3% 01 Nov 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 76,201,185 +6,029,207 +8.6% 27 Jul 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 75,768,936 +14,751,229 +24% 23 Apr 2021 10-Q 27 Apr 2021 2021 Q1
Q4 2020 75,428,927 +14,583,219 +24% 11 Feb 2021 10-K 16 Feb 2021 2020 FY
Q3 2020 70,652,429 +15,448,187 +28% 23 Oct 2020 10-Q 28 Oct 2020 2020 Q3
Q2 2020 70,171,978 +15,509,439 +28% 23 Jul 2020 10-Q 27 Jul 2020 2020 Q2
Q1 2020 61,017,707 +8,107,734 +15% 24 Apr 2020 10-Q 28 Apr 2020 2020 Q1
Q4 2019 60,845,708 07 Feb 2020 10-K 12 Feb 2020 2019 FY
Q3 2019 55,204,242 +3,307,247 +6.4% 24 Oct 2019 10-Q 28 Oct 2019 2019 Q3
Q2 2019 54,662,539 +7,075,678 +15% 25 Jul 2019 10-Q 29 Jul 2019 2019 Q2
Q1 2019 52,909,973 +5,723,144 +12% 25 Apr 2019 10-Q 29 Apr 2019 2019 Q1
Q3 2018 51,896,995 +10,877,643 +27% 01 Nov 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 47,586,861 +6,995,192 +17% 01 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 47,186,829 +7,376,778 +19% 30 Apr 2018 10-Q 08 May 2018 2018 Q1
Q3 2017 41,019,352 03 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 40,591,669 07 Aug 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 39,810,051 01 Mar 2017 10-K 10 Mar 2017 2016 FY
Q4 2016 39,808,801 21 Nov 2016 10-Q 22 Nov 2016 2016 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.